Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | SLC6A9 | P48067 | 9/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SLC8A1 | P32418 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16229760 | 0.93 | KMT2A (0.45) | LMNASLC6A9KMT2AGAAMEN1 | |
| SCHEMBL16229748 | 0.92 | SLC6A9 (0.45) | LMNASLC6A9KMT2AGAAMEN1 | |
| SCHEMBL16229763 | 0.92 | SLC6A9 (0.46) | LMNASLC6A9KMT2AGAAMEN1 | |
| SCHEMBL16229803 | 0.90 | SLC6A9 (0.48) | LMNASLC6A9KMT2AGAAMEN1 | |
| SCHEMBL16229751 | 0.87 | SLC6A9 (0.60) | LMNASLC6A9KMT2AGAAMEN1 | |
| SCHEMBL16229777 | 0.86 | SLC6A9 (0.51) | LMNASLC6A9KMT2AGAAMEN1 | |
| SCHEMBL16229788 | 0.85 | KMT2A (0.41) | LMNASLC6A9KMT2AGAAMEN1 | |
| SCHEMBL16784652 | 0.85 | SLC8A1 (0.37) | LMNASLC6A9KMT2ASLC8A1POLB | |
| SCHEMBL16229768 | 0.84 | SLC6A9 (0.48) | LMNASLC6A9KMT2AGAAMEN1 | |
| SCHEMBL16229811 | 0.83 | SLC6A9 (0.50) | LMNASLC6A9KMT2AGAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051280-B2 | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-06-09 | — | — | US | disclosed |
| US-8883839-B2 | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy | ABBOTT LABORATORIES (US) | 2014-11-11 | — | — | US | disclosed |